NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

Nope. If NWBO used actual patient level data then the comp will be to those patients who match the -L P3 inclusion criterion, not all patients.

Did you not see that in patients with MRD (same as near total resection) the ECA had a MOS of 20.4 months? Given that -L required "intent for near total resection" that would be a closer comp than including biopsies and partials.

More importantly, the RAs can perform a proper analysis only if they have actual data. The idea of trying to read a KM plot and recreating the real data is funny.